Analysis shows cardiac complications higher after SARS-CoV-2 infection than after vaccination; data comes from 40 health care systems, supports continued use of Pfizer, Moderna COVID-19 vaccinations: study

Sample article from our Consumer Wellness

April 4, 2022 (press release) –

Cardiac complications after SARS-CoV-2 infection or mRNA COVID-19 vaccination are low overall but higher after infection than after vaccination, according to an analysis of electronic health record data from 40 health care systems released today by the Centers for Disease Control and Prevention. The authors said the findings support continued use of the Pfizer and Moderna COVID-19 vaccines for all eligible people aged 5 and older.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Dan Rivard
Dan Rivard
- VP Market Development -

We offer built-to-order consumer wellness coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.